The Agence nationale de sécurité du médicament et des produits de santé (French National Agency for the Safety of Medicines and Health Products) shall carry out surveillance and ongoing monitoring of the bodies it has authorised to ensure ongoing compliance with the obligations listed in Article R. 5211-56, under the conditions laid down in Article 5 of Implementing Regulation (EU) No 920/2013.